Optimal revascularization approach in the age of GoogleMaps – can geographical navigational systems help meet STEMI guidelines

Resumen

Time is myocardium. We have known this for decades. Perhaps the most compelling demonstration of this was shown by Weaver et al, ¹ in the Myocardial Infarction Triage and Intervention (MITI) trial when it was demonstrated that fibrinolytic therapy initiated within 70 minutes of symptom onset was associated with a mortality of only 1.2%. We now know that all things being even, primary angioplasty is the preferred approach, but all things are rarely equal. Timely access to a catheterization laboratory and distance to a catheterization lab are two of the important things that are taken into account when deciding whether to treat a STEMI patient with primary angioplasty or fibrinolytic therapy.